RT Journal Article
SR Electronic
T1 PWAS Hub: Exploring Gene-Based Associations of Common Complex Diseases
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.01.20.23300645
DO 10.1101/2024.01.20.23300645
A1 Kelman, Guy
A1 Zucker, Roei
A1 Brandes, Nadav
A1 Linial, Michal
YR 2024
UL http://medrxiv.org/content/early/2024/01/22/2024.01.20.23300645.abstract
AB PWAS (Proteome-Wide Association Study) is an innovative genetic association approach that complements widely-used methods like GWAS (Genome-Wide Association Study). The PWAS platform involves consecutive phases. Initially, machine learning modeling and probabilistic considerations quantified the impact of genetic variants on protein-coding genes’ biochemical functions. Secondly, aggregating the variants per gene for each individual determines a gene-damaging score. Finally, standard statistical tests are activated in the case-control setting to yield statistically significant genes per phenotype. The PWAS Hub offers a user-friendly interface for an in-depth exploration of gene-disease associations from the UK Biobank (UKB). Results from PWAS cover 99 common diseases and conditions, each with over 10,000 diagnosed individuals per phenotype. Users can explore genes associated with these diseases, with separate analyses conducted for males and females. The PWAS Hub lists statistically significant genes associated with common diseases. It also indicates whether the analyzed damaged gene is associated with an increased or decreased risk. For each phenotype, the analyses account for sex-based genetic effects, inheritance modes (dominant and recessive), and the pleiotropic nature of associated genes. The PWAS Hub showcases its usefulness by navigating through such proteomic-genetic application for asthma. Graphical tools facilitate comparing genetic effects between the results of PWAS and coding GWAS, aiding in understanding the sex-specific genetic impact on common diseases. This adaptable platform is attractive for clinicians, researchers, and individuals interested in delving into gene-disease associations and sex-specific genetic effects. The PWAS Hub is accessible at http://pwas.huji.ac.il.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the ISF grant 2753/20 (M.L.) on Sex-dependent genetics, and a grant for large-scale data analysis from the Center for Interdisciplinary Data Science Research (CIDR, #3035000440) at the Hebrew University, Jerusalem (M.L.).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the University Committee for the Use of Human Subjects in Research Approval number 12072022 (July 2023). This study uses the UK-Biobank (UKB) application ID 26664 (Linial lab).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript http://pwas.huji.ac.il